Microporation for Enhanced Transdermal Drug Delivery
Thakur Raghu Raj Singh
School of Pharmacy, Queen's University Belfast, Belfast, UK
Search for more papers by this authorChirag Gujral
School of Pharmacy, Queen's University Belfast, Belfast, UK
Search for more papers by this authorThakur Raghu Raj Singh
School of Pharmacy, Queen's University Belfast, Belfast, UK
Search for more papers by this authorChirag Gujral
School of Pharmacy, Queen's University Belfast, Belfast, UK
Search for more papers by this authorRyan F. Donnelly
School of Pharmacy, Queen's University Belfast, UK
Search for more papers by this authorThakur Raghu Raj Singh
School of Pharmacy, Queen's University Belfast, UK
Search for more papers by this authorRyan F. Donnelly
School of Pharmacy, Queen's University Belfast, UK
Search for more papers by this authorThakur Raghu Raj Singh
School of Pharmacy, Queen's University Belfast, UK
Search for more papers by this authorSummary
Transdermal drug delivery across the highly lipophilic uppermost layer of the skin, the stratum corneum, is highly challenging. Importantly, permeation of hydrophilic small or high molecular weight and charged compounds into the systemic circulation is limited. To successfully deliver hydrophilic drugs, and macromolecular agents of interest, including peptides, DNA and small interfering RNA, many research groups and pharmaceutical companies worldwide are focusing on the use of microporation-based enhancing techniques. These techniques include the use of laser, thermal ablation, electroporation, radiofrequency, ultrasound, high-pressure jets, and microneedle technology. All of these share the common goal of enhancing the permeability of a biological membrane through the creation of transient aqueous transport pathways of micron dimensions across that membrane. Once created, these micropores are orders of magnitude larger than molecular dimensions, and therefore should readily permit the transport of hydrophilic macromolecules. Additionally, microporation devices also enable minimally invasive sampling and monitoring of biological fluids. This Chapter deals with the innovations relating to microporation based methods and devices for transdermal drug delivery and minimally invasive monitoring.
References
- Stachowiak, J.C., Li, T.H., Arora, A. et al. (2009) Dynamic control of needle-free jet injection. J. Control. Release, 135 (2), 104–112.
- Barry, B.W. (2001) Novel mechanisms and devices to enable successful transdermal delivery. Eur. J. Pharm. Sci., 14, 101–114.
- White, S.H., Mirejovsky, D. and King, G.I. (1988) Structure of lamellar lipid domains and corneocyte envelopes of murine stratum corneum: an X-ray diffraction study. Biochemistry, 27, 3725–3732.
- Bouwstra, J.A., Ooris, G.S., Van der spek, J.A. et al. (1994) The lipid and protein structure of mouse stratum corneum: a wide and small angle diffraction study. Biochim. Biophys. Acta, 1212, 183–192.
- Prausnitz, M.R. and Langer, R. (2008) Transdermal drug delivery. Nat. Biotechnol., 26 (11), 1261–1268.
- Lee, J.W., Gadiraju, P., Park, J.H. et al. (2011) Microsecond thermal ablation of skin for transdermal drug delivery. J. Control. Release, 154 (1), 58–68.
- Kalia, Y.N., Naik, A., Garrison, J. and Guy, R.H. (2004) Iontophoretic drug delivery. Adv. Drug Deliv. Rev., 56, 619–658.
- Becker, S., Zorec, B., Miklavčič, D. and Pavšelj, N. (2014pii: S0025-5564(14)00125-4) Transdermal transport pathway creation: electroporation pulse order. Math. Biosci.
- Kim, J., Jang, J.H., Lee, J.H. et al. (2012) Enhanced topical delivery of small hydrophilic or lipophilic active agents and epidermal growth factor by fractional radiofrequency microporation. Pharm. Res., 29 (7), 2017–2029.
- Donnelly, R.F., McCrudden, M.T., Zaid Alkilani, A. et al. (2014) Hydrogel-forming microneedles prepared from ‘super Swelling’ polymers combined with lyophilised wafers for transdermal drug delivery. PLoS One, 9 (10), e111547.
- Mitragotri, S., Blankschtein, D. and Langer, R. (1995) Ultrasound-mediated transdermal protein delivery. Science, 269 (5225), 850–853.
- Baxter, J. and Mitragotri, S. (2005) Jet-induced skin puncture and its impact on needle-free jet injections: experimental studies and a predictive model. J. Control. Release, 106, 361–373.
- Mitragotri, S. (2006) Current status and future prospects of needle-free liquid jet injectors. Nat. Rev. Drug Discov., 5, 543–548.
- Arora, A., Prausnitz, M.R. and Mitragotri, S. (2008) Micro-scale devices for transdermal drug delivery. Int. J. Pharm., 364, 227–236.
- Donnelly, R.F., Morrow, D.I., McCarron, P.A. et al. (2007) Influence of solution viscosity and injection protocol on distribution patterns of jet injectors: application to photodynamic tumour targeting. J. Photochem. Photobiol. B, Biol., 89 (2–3), 98–109.
- Lindmayer, I., Menassa, K., Lambert, J. et al. (1986) Development of new jet injector for insulin therapy. Diabetes Care, 9, 294–297.
- Peter, D.J., Scott, J.P., Watkins, H.C. and Frasure, H.E. (2002) Subcutaneous lidocaine delivered by jet-injector for pain control before IV catheterization in the ED: the patients’ perception and preference. Am. J. Emerg. Med., 20, 562–566.
- Zsigmond, E.K., Darby, P., Koenig, H.M. and Goll, E.F. (1999) Painless intravenous catheterization by intradermal jet injection of lidocaine: a randomized trial. J. Clin. Anesth., 11, 87–94.
- Greenberg, R.S., Maxwell, L.G., Zahurak, M. and Yaster, M. (1995) Preanesthetic medication of children with midazolam using the biojector jet injector. Anesthesiology, 83, 264–269.
- Brodell, R.T. and Bredle, D.L. (1995) The treatment of palmar and plantar warts using natural alpha interferon and a needleless injector. Dermatol. Surg., 21, 213–218.
- Suzuki, T., Takahashi, I. and Takada, G. (1995) Daily subcutaneous erythropoietin by jet injection in pediatric dialysis patients. Nephron, 69, 347.
- Burkoth, T.L., Bellhouse, B.J., Hewson, G. et al. (1999) Transdermal and transmucosal powdered drug delivery. Crit. Rev. Ther. Drug Carrier Syst., 16, 331–384.
- Mitchell, P. (2003) UK biotech sector loses flagship PowderJect to Chiron. Nat. Biotechnol., 21, 717.
- Roberts, L.K., Barr, L.J., Fuller, D.H. et al. (2005) Clinical safety and efficacy of a powdered Hepatitis B nucleic acid vaccine delivered to the epidermis by a commercial prototype device. Vaccine, 23, 4867–4878.
- Wolf, A.R., Stoddart, P.A., Murphy, P.J. and Sasada, M. (2002) Rapid skin anaesthesia using high velocity lignocaine particles: a prospective placebo controlled trial. Arch. Dis. Child., 86, 309–312.
- Longridge, D.J., Sweeney, P.A., Burkoth, T.L. and Bellhouse, B.J. (1998) Effects of particle size and cylinder pressure on dermal PowderJect delivery of testosterone to conscious rabbits. Proc. Int. Symp. Control Rel. Bioact. Mat., 25, 964.
- Arora, A., Mitragotri, S. and Ahmet, T. (2009) Soft tissue augmentation by needle-free injection. US Patent 20,090,030,367.
- Benedek, K., Walker, E., Doshier, L.A. and Stout, R. (2005) Studies on the use of needle-free injection device on proteins. J. Chromatogr. A, 1079, 397–407.
- Houtzagers, C.M., Visser, A.P., Berntzen, P.A. et al. (1988) The medi-jector II: efficacy and acceptability in insulin-dependent diabetic patients with and without needle phobia. Diabet. Med., 5, 135–138.
- Schneider, U., Birnbacher, R. and Schober, E. (1994) Painfulness of needle and jet injection in children with diabetes mellitus. Eur. J. Pediatr., 153, 409–410.
- Hingson, R.A., Davis, H.S. and Rosen, M. (1963) The historical development of jet injection and envisioned uses in mass immunization and mass therapy based upon 2 decade's experience. Mil. Med., 128, 516–524.
- Gratieri, T., Alberti, I., Lapteva, M. and Kalia, Y.N. (2013) Next generation intra- and transdermal therapeutic systems: using non- and minimally-invasive technologies to increase drug delivery into and across the skin. Eur. J. Pharm. Sci., 50 (5), 609–622.
- Mitragotri, S.S., Blankschtein, D. and Langer, R.S. (2000) Transdermal protein delivery or measurement using low-frequency sonophoresis. US Patent 006,018,678A.
- Ng, K. and Lui, Y. (2002) Therapeutic ultrasound: its application in drug delivery. Med. Res. Rev., 22 (2), 204–223.
- Harvey, C.J., Pilcher, J.M., Eckersley, R.J. et al. (2002) Advances in ultrasound. Clin. Radiol., 57, 157–177.
- Machet, L. and Boucaud, A. (2002) Phonophoresis: efficiency, mechanisms and skin tolerance. Int. J. Pharm., 243 (1–2), 1–15.
- Lavon, I. and Kost, J. (2004) Ultrasound and transdermal drug delivery. Drug Discov. Today, 9 (15), 670–676.
- Tachibana, K. and Tachibana, S. (1999) Application of ultrasound energy as a new drug delivery system. Jpn. J. Appl. Phys., 38 (5B), 3014–3019.
- Joshi, A. and Raje, J. (2002) Sonicated transdermal drug transport. J. Control. Release, 83 (1), 13–22.
- Gustavo, M., Yogeshvar, N.K. and Richard, H.G. (2003) Ultrasound-enhanced transdermal transport. J. Pharm. Sci., 92 (6), 1125–1137.
- Park, E.J., Werner, J. and Smith, N.B. (2007) Ultrasound mediated transdermal insulin delivery in pigs using a lightweight transducer. Pharm. Res., 7, 1396–1400.
- Singer, A., Homan, C., Church, A. and McClain, S. (1998) Low-frequency sonophoresis: pathologic and thermal effects in dogs. Acad. Emerg. Med., 5, 35–40.
- Mitragotri, S.S., Blankschtein, D. and Langer, R.S. (1996) Transdermal drug delivery using low-frequency sonophoresis. Pharm. Res., 13, 411–420.
- Batheja, P., Thakur, R. and Michniak, B. (2006) Transdermal iontophoresis. Expert Opin. Drug Deliv., 3, 127–138.
- Williams, A.C. (2003) Transdermal and Topical Drug Delivery, Pharmaceutical Press, London.
- Merino, V., Lopez, A., Kalia, Y.N. and Guy, R.H. (1999) Electrorepulsion versus electroosmosis: effect of pH on the iontophoretic flux of 5-fluorouracil. Pharm. Res., 16, 758–761.
- Lopez, R.F., Bentley, M.V., Delgado-Charro, M.B. and Guy, R.H. (2001) Iontophoretic delivery of 5-aminolevulinic acid (ALA): effect of pH. Pharm. Res., 18, 311–315.
- Bain, K.T. (2006) A patient-activated iontophoretic transdermal system for acute pain management with fentanyl hydrochloride: overview and applications. J. Opioid Manag., 2, 314–324.
- Doliwa, A., Santoyo, S. and Ygartua, P. (2001) Transdermal lontophoresis and skin retention of piroxicam from gels containing piroxicam: hydroxypropyl-beta-cyclodextrin complexes. Drug Dev. Ind. Pharm., 27, 751–758.
- Al-Khalili, M., Meidan, V.M. and Michniak, B.B. (2003) Iontophoretic transdermal delivery of buspirone hydrochloride in hairless mouse skin. AAPS PharmSci, 5 (2), E14.
- Ita, K.B. and Banga, A.K. (2009) In vitro transdermal iontophoretic delivery of penbutolol sulfate. Drug Deliv., 16 (1), 11–14.
- Fourie, L., Breytenbach, J.C., Du Plessis, J. et al. (2004) Percutaneous delivery of carbamazepine and selected N-alkyl and N-hydroxyalkyl analogues. Int. J. Pharm., 279, 59–66.
- Nair, V. and Panchagnula, R. (2003) Physicochemical considerations in the iontophoretic delivery of a small peptide: in vitro studies using arginine vasopressin as a model peptide. Pharmacol. Res., 48, 175–182.
- Nakamura, K., Katagai, K., Mori, K. et al. (2001) Transdermal administration of salmon calcitonin by pulse depolarization- iontophoresis in rats. Int. J. Pharm., 218, 93–102.
- Heit, M.C., Monteiro-Riviere, N.A., Jayes, F.L. and Riviere, J.E. (1994) Transdermal iontophoretic delivery of luteinizing hormone releasing hormone (LHRH): effect of repeated administration. Pharm. Res., 11, 1000–1003.
- Leboulanger, B., Fathi, M., Guy, R.H. and Delgado-Charro, M.B. (2004) Reverse iontophoresis as a noninvasive tool for lithium monitoring and pharmacokinetic profiling. Pharm. Res., 21, 1214–1222.
- Touitou, E. (2002) Drug delivery across the skin. Expert Opin. Biol. Ther., 2, 723–733.
- Sung, K.C., Fang, J.Y., Wang, J.J. and Hu, O.Y. (2003) Transdermal delivery of nalbuphine and its prodrugs by electroporation. Eur. J. Pharm. Sci., 18, 63–70.
- Wallace, M.S., Ridgeway, B., Jun, E. et al. (2001) Topical delivery of lidocaine in healthy volunteers by electroporation, electroincorporation, or iontophoresis: an evaluation of skin anesthesia. Reg. Anesth. Pain Med., 26, 229–238.
- Wang, S., Kara, M. and Krishnan, T.R. (1998) Transdermal delivery of cyclosporin-A using electroporation. J. Control. Release, 50, 61–70.
- Conjeevaram, R., Banga, A.K. and Zhang, L. (2002) Electrically modulated transdermal delivery of fentanyl. Pharm. Res., 19, 440–444.
- Prausnitz, M.R., Edelman, E.R., Gimm, J.A. et al. (1995) Transdermal delivery of heparin by skin electroporation. Biotechnology, 13, 1205–1209.
- Medi, B.M. and Singh, J. (2003) Electronically facilitated transdermal delivery of human parathyroid hormone (1–34). Int. J. Pharm., 263, 25–33.
- Drabick, J.J., Glasspool-Malone, J., King, A. and Malone, R.W. (2001) Cutaneous transfection and immune responses to intradermal nucleic acid vaccination are significantly enhanced by in vivo electropermeabilization. Mol. Ther., 3, 249–255.
- Nelson, J.S., McCullough, J.L., Glenn, T.C. et al. (1991) Midinfrared laser ablation of stratum corneum enhances in vitro percutaneous transport of drugs. J. Invest. Dermatol., 97, 874–879.
- Fang, J.Y., Lee, W.R., Shen, S.C. et al. (2004) Enhancement of topical 5-aminolaevulinic acid delivery by erbium:YAG laser and microdermabrasion: a comparison with iontophoresis and electroporation. Br. J. Dermatol., 151, 132–140.
- Shen, S.C., Lee, W.R., Fang, Y.P. et al. (2006) In vitro percutaneous absorption and in vivo protoporphyrin IX accumulation in skin and tumors after topical 5-aminolevulinic acid application with enhancement using an erbium:YAG laser. J. Pharm. Sci., 95, 929–938.
- Lee, W.R., Shen, S.C., Lai, H.H. et al. (2001b) Transdermal drug delivery enhanced and controlled by erbium:YAG laser: a comparative study of lipophilic and hydrophilic drugs. J. Control. Release, 75, 155–166.
- Lee, W.R., Shen, S.C., Liu, C.R. et al. (2006) Erbium:YAG laser-mediated oligonucleotide and DNA delivery via the skin: an animal study. J. Control. Release, 115, 344–353.
- Bragagna, T., Reinhard, B., Daniel, G. et al. (2006) WO2006111429.
- Bragagna, T., Reinhard, B., Daniel, G. and Bernhard, N. (2005) Laser microporator. EP051704.
- Bragagna, T., Reinhard, B., Daniel, G. and Bernhard, N. (2006) Microporator for parating a biological membran and integrated permeant administering system. WO2006111199.
- Bragagna, T., Reinhard, B., Daniel, G. and Bernhard, N. (2006) Microporator for creating a permeation surface. WO2006111200.
- http://www.please-professional.com/en/research/combination-treatments
- Bach, D., Weiss, R., Hessenberger, M. et al. (2012) Transcutaneous immunotherapy via laser-generated micropores efficiently alleviates allergic asthma in Phl p 5-sensitized mice. Allergy, 67 (11), 1365–1374.
- Konno, Y., Kawata, H., Aruga, M. et al. (1987) Patch. US Patent 4,685,911.
- Kuratomi, Y. and Miyauchi, K. (1988) Methods and instruments of moxibustion. US Patent 4,747,841.
- Ajay, K.B. (2006) Therapeutic Peptides and Proteins: Formulation, Processing, and Delivery Systems, 2nd edn, CRC Taylor & Francis, Boca Raton, pp. 264–265.
- Stewart, R.F. (1989) Temperature-controlled active agent dispenser. US Patent 4,830,855.
- Badkar, A.V., Smith, A.M., Eppstein, J.A. and Banga, A.K. (2007) Transdermal delivery of interferon alpha-2B using microporation and iontophoresis in hairless rats. Pharm. Res., 24, 1389–1395.
- Eppstein, J.A. (1998) Microporation of tissue for delivery of bioactive agents. WO98029134.
- Levin, G., Amikan, G., Meir, S. and Amir, S. (2007) Combined micro-channel generation and iontophoresis for transdermal delivery of pharmaceutical agents. US Patent 20,070,260,170.
- http://www.nitto.com/jp/en/press/2012/0425.jsp
- Sintov, A.C., Krymberk, I., Daniel, D. et al. (2003) Radiofrequency-driven skin microchanneling as a new way for electrically assisted transdermal delivery of hydrophilic drugs. J. Control. Release, 89, 311–320.
- Gerstel, M.S. and Place V.A. (1976) Drug delivery device. US Patent 3,964,482.
- Henry, S., McAllister, D.V., Allen, M.G. and Prausnitz, M.R. (1998) Microfabricated microneedles: a novel approach to transdermal drug delivery. J. Pharm. Sci., 87 (8), 922–925.
- Prausnitz, M.R. (2004) Microneedles for transdermal drug delivery. Adv. Drug Deliv. Rev., 56 (5), 581–587.
-
Donnelly, R.F., Thakur, R.R.S., Morrow, D.I.J. and Woolfson, A.D. (2012) Microneedle-Mediated Transdermal and Intradermal Drug Delivery, Wiley-Blackwell, Oxford.
10.1002/9781119959687 Google Scholar